Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury

Acute Kidney Injury Clinical Trial

Official title:

Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02347930
• Other study ID #: 2014DFT30090
• Status: Completed
• Start date: April 2014
• Est. completion date: December 30, 2017

Study information

• Verified date: November 2023
• Source: RenJi Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Establish an integrated evaluation system of ultrasound technology for the prognosis of acute kidney injury, and in order to achieve non-invasive, reliable early diagnosis "gold standard". Set up collabration with the expert in National Cheng Kung University Medical Center of Taiwan who did a lot of excellent work in basic research of prevention the progression of acut kidney injury. Study the experience about prevention progression of kidney disease in clinical and basic field. Establish cooperation with the professional in Hong Kong University of Science and Technology. To set up the system of natural products research and assess the Astragalus medicinal value.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 196
• Est. completion date: December 30, 2017
• Est. primary completion date: November 15, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Subjects must satisfy the following criteria to be enrolled in the study:

1. Clinical diagnosis of acute or chronic kidney injury

2. Male or female, aged 18-80 years old

3. signed informed consent

4. Patients can breathe in, breathe out and hold their breathe with ease, communication without difficulty.

Exclusion Criteria:

• Potential subjects who meet any of the following criteria will be excluded from participating in the study:

1. Refuse to sign informed consent

2. allergy to micro bubble hexafluoride drug

3. Patients with cardiopulmonary insufficiency, pleural effusion, pulmonary infections

4. Patients with asthma, chronic bronchitis

5. Patients with pregnancy

6. Patients can't cooperate or have a difficulty in breathing in, breathing out or holding their breathe

7. Patients beening diagnosed with End-stage kidney disease.

Related Conditions & MeSH terms

• Acute Kidney Injury
• Wounds and Injuries

Intervention

Other:
• kidney ultrasound
kidney ultrasound

Locations

Country	Name	City	State
China	Department of nephrology , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine	Shanghai	Shanghai

Sponsors (3)

Lead Sponsor	Collaborator
RenJi Hospital	China-Japan Friendship Hospital, National Cheng-Kung University Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	compare the results of kidney ultrasound with biomarkers of acute kidney injury		up to 24 months